Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-08-20. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001100682-26-000138
acquired disposedD
codeG
direct or indirectD
form4
is derivativefalse
issuer nameCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
labelGift
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001100682-26-000138",
"acquired_disposed": "D",
"code": "G",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
"label": "Gift",
"person_name": "Girshick Birgit",
"price": 0,
"role": "Director, Chief Executive Officer",
"security": "Common Stock",
"shares": 528,
"shares_owned_after": 35485,
"source_path": "edgar/data/1100682/0001100682-26-000138.txt",
"ticker": "CRL",
"transaction_date": "2026-08-19",
"value": null
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.